Drug Lab

Multidisciplinary team focused on understanding substance use disorders

Research in the Drug Lab focuses on mechanism-based determinants and modification of addictive behaviors. Our lab uses rigorous human experimental approaches, medications and pharmacological probes, multi-modal magnetic resonance imaging, neuromodulation, and behavioral, subjective and physiological endpoints to investigate hypothesized relationships.

There are several ongoing projects in the lab. Students at various levels of training (e.g. postdoctoral, graduate, medical, undergraduate) are routinely involved in our research and obtain mentored scientific experiences. Beyond these studies, we are actively engaged in several other collaborative projects with other labs at Wayne State University and across the country.

 

Our Current Projects

 
 
Project Start: Spring 2021ONGOING

Project Start: Spring 2021

ONGOING

Sleep and Substance Use

Orexin receptors play a role in the regulation of sleep and wakefulness. They may also play a role in stress and substance use behaviors. It is possible that orexin receptors may influence opioid use through a variety of methods. This project looks at the effects of an antagonist of these receptors (suvorexant) and how this medication impacts opioid abstinence in patients with opioid use disorder. This project will enable us to determine whether resolving disturbances in sleep (restoration of sleep efficiency) is important in reducing opioid use/relapse.

Review paper: At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities

 
Project Start: Summer 2020ONGOING

Project Start: Summer 2020

ONGOING

Transcranial Magnetic Stimulation

Repetitive transcranial magnetic stimulation (rTMS) can be used to modify a variety of neural functions. Stimulation at frontal-cortical sites (dorsolateral prefrontal and medial prefrontal) can be used to alter executive function and stress-induced behavior, including drug-seeking behavior. We are studying these effects in both healthy persons and those with opioid use disorder.

 
ONGOING

ONGOING

Contingency Management

Contingency management (CM) treatments are efficacious in improving behavioral outcomes and reducing substance use. In CM treatments, patients are rewarded for successfully meeting certain behavioral outcomes (e.g. 1 week of smoking abstinence). We explore a variety of ways that CM can be used in substance use treatment.

Publications:

1) Contingency management interventions for tobacco and other substance use disorders in pregnancy

2) Contingency management for individuals with chronic health conditions: A systematic review and meta-analysis of randomized controlled trials

 
ONGOING

ONGOING

Stress and Substance Use

Stress can increase and/or maintain drug seeking and use in laboratory animal and there is evidence to suggest it has the same impact in humans; however, until now there have been no well-controlled human studies to explore how stress impacts substance use. We seek to understand how stress impacts use of opioids in people who are currently using opioids.

Selected Publications:

1) Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework

2) Yohimbine increases opioid-seeking behavior in heroin-dependent, buprenorphine-maintained individuals

 
ONGOING

ONGOING

Polysubstance Use

Epidemiological studies suggest greater health risks among opioid users who also use sedating substances (e.g. alcohol, benzodiazepines). Our research indicates that consequences of chronic heroin use are greater among non-medical (but not prescription) sedative users. We are using neurocognitive testing to understand how opioid/sedative polydrug users differ from primary opioid users (controlling for other substance use and psychiatric co-factors).

Selected Papers:

1) Factors associated with sedative use and misuse among heroin users

2) History of regular nonmedical sedative and/or alcohol use differentiates substance-use patterns and consequences among chronic heroin users

3) Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder

 
ONGOING

ONGOING

Cannabis Use, Cues, and Craving

Cannabis use can occur in a variety of situations and there are often cues that may cause a person to feel craving to use cannabis. Our lab explores cannabis use and craving and examines the effects of drug cue-exposure on cannabis-seeking behavior in regular cannabis users. 

Selected Papers:

1) Demographic, Cannabis Use, and Depressive Correlates of Cannabis Use Consequences in Regular Cannabis Users

2) Beyond the Bud: Emerging Methods of Cannabis Consumption for Youth

 
ONGOING

ONGOING

Problem and Disordered Gambling

Problem and disordered gambling can have a significant impact on a person’s life. We research factors associated with problem gambling and interventions to help people who are experiencing a problem with gambling. 

Selected Publications:

1) Clinical and Personality Characteristics of Problem and Pathological Gamblers With and Without Symptoms of Adult ADHD

2) Gambling-Related Cognitive Distortions in Residential Treatment for Gambling Disorder

 

Substance Use Consequences

Consequences from chronic substance use may be driven by pre-existing factors, and may influence current functional status. Yet, inter-relationships among impulsivity, drug-use consequences and mood/stress are poorly understood.

Selected Publications:

1) Developing a scale of domains of negative consequences of chronic heroin use

2) Mediational pathways among trait impulsivity, heroin-use consequences, and current mood state

 
RTX67MCM-e1570650996471.jpg

Naloxone Access & Use

Consequences from chronic substance use may be driven by pre-existing factors, and may influence current functional status. Yet, inter-relationships among impulsivity, drug-use consequences and mood/stress are poorly understood

 

Self-Medication For People With Substance Use Disorders

There are a variety of complicated reasons that people choose to use illicit substances or misuse prescription medications. We are working to elucidate some of the motivations behind use of different substances in people with opioid use disorder.

Neuroimmune System

The neuroimmune system, principally composed of microglia and astrocytes, may be disrupted by chronic substance use. Further, recent evidence suggests that disruption to the neuroimmune system may contribute to the development and/or perpetuation of substance use disorders, and thus, may be a therapeutic target. Ongoing research in our lab is investigating the role of the neuroimmune system, using multimodal in vivo neuroimaging, in opioid use disorder, cigarette smoking, and chronic pain.